Peter K. Law

1.5k total citations
67 papers, 1.0k citations indexed

About

Peter K. Law is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Peter K. Law has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 23 papers in Surgery and 14 papers in Physiology. Recurrent topics in Peter K. Law's work include Muscle Physiology and Disorders (33 papers), Tissue Engineering and Regenerative Medicine (15 papers) and Adipose Tissue and Metabolism (9 papers). Peter K. Law is often cited by papers focused on Muscle Physiology and Disorders (33 papers), Tissue Engineering and Regenerative Medicine (15 papers) and Adipose Tissue and Metabolism (9 papers). Peter K. Law collaborates with scholars based in United States, China and Singapore. Peter K. Law's co-authors include Tena G. Goodwin, H. L. Atwood, Lei Ye, Eugene K.W. Sim, Husnain Kh Haider, Ruowen Ge, J. Ann Florendo, Shujia Jiang, Liping Su and Ru‐San Tan and has published in prestigious journals such as Nature, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Peter K. Law

62 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter K. Law United States 18 770 344 242 178 133 67 1.0k
Terry Partridge United Kingdom 9 964 1.3× 313 0.9× 304 1.3× 90 0.5× 78 0.6× 15 1.2k
Alberto Malerba United Kingdom 21 875 1.1× 173 0.5× 224 0.9× 111 0.6× 96 0.7× 48 1.1k
Luisa Boldrin United Kingdom 23 1.1k 1.4× 617 1.8× 368 1.5× 194 1.1× 78 0.6× 30 1.5k
Janet R. Bogan United States 18 864 1.1× 236 0.7× 139 0.6× 124 0.7× 83 0.6× 24 959
Daniel J. Bogan United States 18 838 1.1× 228 0.7× 116 0.5× 129 0.7× 98 0.7× 23 977
M. Coletta Italy 10 637 0.8× 338 1.0× 221 0.9× 62 0.3× 48 0.4× 14 819
Brigitte Roy Canada 19 1.2k 1.5× 648 1.9× 512 2.1× 131 0.7× 80 0.6× 24 1.4k
Chiara Rinaldi Italy 13 1.0k 1.3× 342 1.0× 327 1.4× 153 0.9× 76 0.6× 24 1.3k
Shannon M. Sheehan United States 8 874 1.1× 425 1.2× 239 1.0× 111 0.6× 64 0.5× 11 1.1k
Sharon Gerecht‐Nir Israel 14 1.4k 1.8× 559 1.6× 160 0.7× 651 3.7× 161 1.2× 17 1.8k

Countries citing papers authored by Peter K. Law

Since Specialization
Citations

This map shows the geographic impact of Peter K. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Law more than expected).

Fields of papers citing papers by Peter K. Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Law. The network helps show where Peter K. Law may publish in the future.

Co-authorship network of co-authors of Peter K. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Law. A scholar is included among the top collaborators of Peter K. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Law. Peter K. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Law, Peter K.. (2023). Opportunism for Survival: Steamship Teaboys and China's Wartime Shipping Industry, 1937–1941. International Labor and Working-Class History. 105. 104–119.
2.
Law, Peter K. & Jun Ren. (2023). Genetic Cell Therapy in Anti-Aging Regenerative Cosmetology. 12(1). 1–20.
3.
Ye, Lei, Husnain Kh Haider, Liping Su, et al.. (2008). Liposome‐based vascular endothelial growth factor‐165 transfection with skeletal myoblast for treatment of ischaemic limb disease. Journal of Cellular and Molecular Medicine. 14(1-2). 323–336. 7 indexed citations
4.
Ye, Lei, Husnain Kh Haider, Ru‐San Tan, et al.. (2008). Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials. 29(13). 2125–2137. 28 indexed citations
5.
Guo, Changfa, Husnain Kh Haider, Winston Shim, et al.. (2007). Myoblast-based cardiac repair: Xenomyoblast versus allomyoblast transplantation. Journal of Thoracic and Cardiovascular Surgery. 134(5). 1332–1339.e2. 11 indexed citations
6.
Law, Peter K., et al.. (2006). Human myoblast genome therapy. Journal of Geriatric Cardiology. 3(3). 135–151. 1 indexed citations
7.
Ye, Lei, Husnain Kh Haider, Shujia Jiang, et al.. (2006). Improved Angiogenic Response in Pig Heart Following Ischaemic Injury Using Human Skeletal Myoblast Simultaneously Expressing VEGF165 and Angiopoietin-1. European Journal of Heart Failure. 9(1). 15–22. 32 indexed citations
8.
Ye, Lei, Husnain Kh Haider, Shujia Jiang, et al.. (2005). Reversal of Myocardial Injury Using Genetically Modulated Human Skeletal Myoblasts in a Rodent Cryoinjured Heart Model. European Journal of Heart Failure. 7(6). 945–952. 17 indexed citations
9.
Ye, Lei, Husnain Kh Haider, Shujia Jiang, et al.. (2005). In Vitro Functional Assessment of Human Skeletal Myoblasts After Transduction With Adenoviral Bicistronic Vector Carrying Human VEGF165 and Angiopoietin-1. The Journal of Heart and Lung Transplantation. 24(9). 1393–1402. 16 indexed citations
10.
Law, Peter K.. (2004). 1025-65 First human heart myoblast allograft. Journal of the American College of Cardiology. 43(5). A39–A39. 1 indexed citations
11.
Law, Peter K., et al.. (2004). Human VEGF165-myoblasts produce concomitant angiogenesis/myogenesis in the regenerative heart. Molecular and Cellular Biochemistry. 263(1). 173–178. 11 indexed citations
12.
Haider, Husnain Kh, et al.. (2004). Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplantation Proceedings. 36(1). 232–235. 16 indexed citations
13.
Haider, Husnain Kh, Lei Ye, Shujia Jiang, et al.. (2004). Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. Journal of Molecular Medicine. 82(8). 539–549. 55 indexed citations
14.
Ye, Lei, Husnain Kh Haider, Shujia Jiang, et al.. (2003). High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies. Experimental & Molecular Medicine. 35(5). 412–420. 10 indexed citations
15.
Law, Peter K., et al.. (1997). Human gene therapy with myoblast transfer. Transplantation Proceedings. 29(4). 2234–2237. 13 indexed citations
16.
Law, Peter K., et al.. (1991). Myoblast Transfer Therapy for Duchenne Muscular Dystrophy. Pediatrics International. 33(2). 206–215. 29 indexed citations
17.
Law, Peter K., et al.. (1990). Plausible Structural/Functional/Behavioral/Biochemical Transformations Following Myoblast Transfer Therapy. Advances in experimental medicine and biology. 280. 241–250. 3 indexed citations
18.
Law, Peter K., et al.. (1988). Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle & Nerve. 11(6). 525–533. 92 indexed citations
19.
Borum, Peggy R., et al.. (1978). Altered tissue carnitine levels in animals with hereditary muscular dystrophy. Journal of the Neurological Sciences. 38(1). 113–121. 14 indexed citations
20.
Law, Peter K. & H. L. Atwood. (1971). Membrane resistance change induced by nitrate and other anions in long and short sarcomere muscle fibres of crayfish. Comparative Biochemistry and Physiology Part A Physiology. 40(1). 265–271. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry Partridge Breakdown of academic impact, for papers by Alberto Malerba Breakdown of academic impact, for papers by Luisa Boldrin Breakdown of academic impact, for papers by Janet R. Bogan Breakdown of academic impact, for papers by Daniel J. Bogan Breakdown of academic impact, for papers by M. Coletta Breakdown of academic impact, for papers by Brigitte Roy Breakdown of academic impact, for papers by Chiara Rinaldi Breakdown of academic impact, for papers by Shannon M. Sheehan Breakdown of academic impact, for papers by Sharon Gerecht‐Nir
Rankless by CCL
2026